Aspirin therapy should be first-line treatment in secondary prevention of stroke--against

Stroke. 2002 Aug;33(8):2138-9. doi: 10.1161/01.str.0000023102.03179.30.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aspirin / adverse effects
  • Aspirin / therapeutic use*
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / drug therapy
  • Clopidogrel
  • Dipyridamole / therapeutic use
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Drug Therapy, Combination
  • Humans
  • Ischemic Attack, Transient / complications
  • Ischemic Attack, Transient / drug therapy
  • Multicenter Studies as Topic
  • Platelet Aggregation Inhibitors / adverse effects
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Risk
  • Stroke / drug therapy*
  • Stroke / etiology
  • Stroke / prevention & control*
  • Ticlopidine / adverse effects
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use*
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Dipyridamole
  • Clopidogrel
  • Ticlopidine
  • Aspirin